Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Feverish activity

Abilify (Bristol-Myers Squibb and Otsuka Pharmaceutical). Treatment of schizophrenia, acute manic and mixed episodes.

Week in Review Editorial: 10 to 16 August

Bristol-Myers Squibb and Otsuka's Abilify.

Fitch removes BMS negative ratings watch

Fitch says that the revenue decline of 2006 to reverse this year was halted by growth of Bristol-Myers five leading drug products, Plavix, Abilify, Avapro/Avalide, Reyataz and Sustiva.

News in brief, June 07, 2007

the use of Abilify in 302 ethnically diverse paediatric patients and was conducted at 101 centres in 13 countries. ... Based on IMS sales data ending in January 2007, Abilify was worth USD 1.9bn in annual sales.

Sativex alliance between GW and Otsuka in the US

Otsuka's main therapeutic focus is on CNS treatments, as its main product is schizophrenia treatment, Abilify (aripiprazole), which it co-markets in the.

[ Previous 5 results ] 12 13 14 15 16

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

OPEN Health Graduates and the XP Support Group
During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision...
Alexander Devine Website has gone live!
As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics